FRESENIUS MEDICAL CARE AG Impairment Loss Recognised In Profit Or Loss
FRESENIUS MEDICAL CARE AG (FMS) reported Impairment Loss Recognised In Profit Or Loss of EUR 1.42 million for the 3-month period ending 2024-06-30, per its 6-K filed 2024-07-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ImpairmentLossRecognisedInProfitOrLoss · last filed 2024-07-30
- FRESENIUS MEDICAL CARE AG impairment loss recognised in profit or loss for the quarter ending 2024-06-30 was 1.42M EUR, a 89.20% decline year-over-year.
- FRESENIUS MEDICAL CARE AG impairment loss recognised in profit or loss for the quarter ending 2024-03-31 was 1.05M EUR, a 95.70% decline year-over-year.
- FRESENIUS MEDICAL CARE AG impairment loss recognised in profit or loss for the quarter ending 2023-12-31 was 5.48M EUR, a 89.67% decline year-over-year.
- FRESENIUS MEDICAL CARE AG impairment loss recognised in profit or loss for the quarter ending 2023-09-30 was 5.84M EUR, a 91.26% decline year-over-year.
| Period end | Impairment Loss Recognised In Profit Or Loss 3 month | Impairment Loss Recognised In Profit Or Loss 6 month | Impairment Loss Recognised In Profit Or Loss 9 month | Impairment Loss Recognised In Profit Or Loss 12 month |
|---|---|---|---|---|
| 2024-06-30 | 1.42M EUR 6-K · filed 2024-07-30 | 2.46M EUR 6-K · filed 2024-07-30 | 7.94M EUR derived: sum of 3 quarters · filed 2024-07-30 | 13.78M EUR derived: sum of 4 quarters · filed 2024-07-30 |
| 2024-03-31 | 1.05M EUR 6-K · filed 2024-05-07 | 6.53M EUR derived: sum of 2 quarters · filed 2024-05-07 | 12.37M EUR derived: sum of 3 quarters · filed 2024-05-07 | 25.49M EUR derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-12-31 | 5.48M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 11.32M EUR derived: sum of 2 quarters · filed 2024-02-20 | 24.44M EUR derived: sum of 3 quarters · filed 2024-07-30 | 48.77M EUR 20-F · filed 2024-02-20 |
| 2023-09-30 | 5.84M EUR 6-K · filed 2023-11-02 | 18.96M EUR derived: sum of 2 quarters · filed 2024-07-30 | 43.29M EUR 6-K · filed 2023-11-02 | 96.31M EUR derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-06-30 | 13.12M EUR 6-K · filed 2024-07-30 | 37.45M EUR 6-K · filed 2024-07-30 | 90.47M EUR derived: sum of 3 quarters · filed 2024-07-30 | 157.33M EUR derived: sum of 4 quarters · filed 2024-07-30 |
| 2023-03-31 | 24.33M EUR 6-K · filed 2024-05-07 | 77.34M EUR derived: sum of 2 quarters · filed 2024-05-07 | 144.21M EUR derived: sum of 3 quarters · filed 2024-05-07 | |
| 2022-12-31 | 53.02M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-20 | 119.88M EUR derived: sum of 2 quarters · filed 2024-02-20 | 123.58M EUR 20-F · filed 2024-02-20 | |
| 2022-09-30 | 66.86M EUR 6-K · filed 2023-11-02 | 70.56M EUR 6-K · filed 2023-11-02 | ||
| 2021-12-31 | 37.55M EUR 20-F · filed 2024-02-20 | |||
| 2021-06-30 | 8.67M EUR 6-K · filed 2021-07-30 | 8.97M EUR 6-K · filed 2021-07-30 | ||
| 2021-03-31 | 296.00K EUR 6-K · filed 2021-05-06 | |||
| 2020-12-31 | 199.03M EUR 20-F · filed 2021-02-23 | |||
| 2020-06-30 | 5.41M EUR 6-K · filed 2021-07-30 | 6.42M EUR 6-K · filed 2021-07-30 | ||
| 2020-03-31 | 1.01M EUR 6-K · filed 2021-05-06 | |||
| 2019-12-31 | 39.75M EUR 20-F · filed 2021-02-23 | |||
| 2018-12-31 | 64.72M EUR 20-F · filed 2021-02-23 |